S. Adámi

Effects of strontium ranelate on spinal osteoarthritis progression

T. Spector, J. Reginster, O. Bruyère, 2007, Annals of the rheumatic diseases.

osteoarthritis progression Effects of strontium ranelate on spinal

T. Spector, J. Wark, C. Roux, 2008 .

Loss of hip bone mineral density over time is associated with spine and hip fracture incidence in osteoporotic postmenopausal women

M. Hiligsmann, J. Reginster, V. Rabenda, 2009, European Journal of Epidemiology.

Odanacatib anti-fracture efficacy and safety in postmenopausal women with osteoporosis: results from the phase III long-term odanacatib fracture trial

Zanchetta, D. Kiel, J. Reginster, 2015 .

Controversial issues in climacteric medicine IV Postmenopausal osteoporosis: therapeutic options

C. Christiansen, C. Campagnoli, J. Kanis, 2005 .

relationship between total hip BMD T-score and incidence of nonvertebral fracture with up to 10 years of Denosumab (DMAB) treatment

Jacques P. Brown, J. Reginster, E. Lewiecki, 2016 .